Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33


Interspecies Outer Membrane Vesicles (OMVs) Modulate the Sensitivity of Pathogenic Bacteria and Pathogenic Yeasts to Cationic Peptides and Serum Complement.

Roszkowiak J, Jajor P, Guła G, Gubernator J, Żak A, Drulis-Kawa Z, Augustyniak D.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5577. doi: 10.3390/ijms20225577.


Human body symmetry and immune efficacy in healthy adults.

Pawlowski B, Borkowska B, Nowak J, Augustyniak D, Drulis-Kawa Z.

Am J Phys Anthropol. 2018 Oct;167(2):207-216. doi: 10.1002/ajpa.23617. Epub 2018 Sep 20.


Neuropeptides SP and CGRP Diminish the Moraxella catarrhalis Outer Membrane Vesicle- (OMV-) Triggered Inflammatory Response of Human A549 Epithelial Cells and Neutrophils.

Augustyniak D, Roszkowiak J, Wiśniewska I, Skała J, Gorczyca D, Drulis-Kawa Z.

Mediators Inflamm. 2018 Aug 5;2018:4847205. doi: 10.1155/2018/4847205. eCollection 2018.


No evidence for the immunocompetence handicap hypothesis in male humans.

Nowak J, Pawłowski B, Borkowska B, Augustyniak D, Drulis-Kawa Z.

Sci Rep. 2018 May 9;8(1):7392. doi: 10.1038/s41598-018-25694-0.


Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution.

Augustyniak D, Seredyński R, McClean S, Roszkowiak J, Roszniowski B, Smith DL, Drulis-Kawa Z, Mackiewicz P.

Sci Rep. 2018 Mar 21;8(1):4955. doi: 10.1038/s41598-018-23029-7.


Body height and immune efficacy: testing body stature as a signal of biological quality.

Pawłowski B, Nowak J, Borkowska B, Augustyniak D, Drulis-Kawa Z.

Proc Biol Sci. 2017 Jul 26;284(1859). pii: 20171372. doi: 10.1098/rspb.2017.1372.


Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly.

Augustyniak D, Majkowska-Skrobek G, Roszkowiak J, Dorotkiewicz-Jach A.

Curr Med Chem. 2017 Nov 24;24(36):4002-4037. doi: 10.2174/0929867324666170508110222. Review.


Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma.

Niedźwiecka K, Dyląg M, Augustyniak D, Majkowska-Skrobek G, Cal-Bąkowska M, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Oncotarget. 2016 Oct 4;7(40):65614-65626. doi: 10.18632/oncotarget.11592.


Modification biological activity of S and R forms of Proteus mirabilis and Burkholderia cepacia lipopolysaccharides by carrageenans.

Arabski M, Barabanova A, Gałczyńska K, Węgierek-Ciuk A, Dzidowska K, Augustyniak D, Drulis-Kawa Z, Lankoff A, Yermak I, Molinaro A, Kaca W.

Carbohydr Polym. 2016 Sep 20;149:408-14. doi: 10.1016/j.carbpol.2016.04.079. Epub 2016 Apr 20.


Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes Remodeling of Extracellular Matrix and Wound Closure Activation.

Styrczewska M, Kostyn A, Kulma A, Majkowska-Skrobek G, Augustyniak D, Prescha A, Czuj T, Szopa J.

Biomed Res Int. 2015;2015:862391. doi: 10.1155/2015/862391. Epub 2015 Aug 4.


Correction: Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.

Danis-Wlodarczyk K, Olszak T, Arabski M, Wasik S, Majkowska-Skrobek G, Augustyniak D, Gula G, Briers Y, Jang HB, Vandenheuvel D, Duda KA, Lavigne R, Drulis-Kawa Z.

PLoS One. 2015 Aug 25;10(8):e0137015. doi: 10.1371/journal.pone.0137015. eCollection 2015. No abstract available.


Isolation and Characterization of Phages Infecting Bacillus subtilis.

Krasowska A, Biegalska A, Augustyniak D, Łoś M, Richert M, Łukaszewicz M.

Biomed Res Int. 2015;2015:179597. doi: 10.1155/2015/179597. Epub 2015 Jul 26.


Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains.

Cullen L, Weiser R, Olszak T, Maldonado RF, Moreira AS, Slachmuylders L, Brackman G, Paunova-Krasteva TS, Zarnowiec P, Czerwonka G, Reilly J, Drevinek P, Kaca W, Melter O, De Soyza A, Perry A, Winstanley C, Stoitsova SR, Lavigne R, Mahenthiralingam E, Sá-Correia I, Coenye T, Drulis-Kawa Z, Augustyniak D, Valvano MA, McClean S.

Microbiology. 2015 Oct;161(10):1961-77. doi: 10.1099/mic.0.000155. Epub 2015 Aug 6.


Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.

Danis-Wlodarczyk K, Olszak T, Arabski M, Wasik S, Majkowska-Skrobek G, Augustyniak D, Gula G, Briers Y, Jang HB, Vandenheuvel D, Duda KA, Lavigne R, Drulis-Kawa Z.

PLoS One. 2015 May 21;10(5):e0127603. doi: 10.1371/journal.pone.0127603. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137015.


Modern Therapeutic Approaches Against Pseudomonas aeruginosa Infections.

Dorotkiewicz-Jach A, Augustyniak D, Olszak T, Drulis-Kawa Z.

Curr Med Chem. 2015;22(14):1642-64. Review.


In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.

Olszak T, Zarnowiec P, Kaca W, Danis-Wlodarczyk K, Augustyniak D, Drevinek P, de Soyza A, McClean S, Drulis-Kawa Z.

Appl Microbiol Biotechnol. 2015 Jul;99(14):6021-33. doi: 10.1007/s00253-015-6492-6. Epub 2015 Mar 12.


Bactericidal, opsonophagocytic and anti-adhesive effectiveness of cross-reactive antibodies against Moraxella catarrhalis.

Augustyniak D, Piekut M, Majkowska-Skrobek G, Skała J.

Pathog Dis. 2015 Apr;73(3). pii: ftu026. doi: 10.1093/femspd/ftu026. Epub 2015 Jan 15.


Serum and urinary MIP-1α and IP-10 levels in children with urinary tract infections.

Gorczyca D, Augustyniak D, Basiewicz-Worsztynowicz B, Karnas-Kalemba W.

Adv Clin Exp Med. 2014 Nov-Dec;23(6):933-8. doi: 10.17219/acem/37341.


Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy.

Majkowska-Skrobek G, Augustyniak D, Lis P, Bartkowiak A, Gonchar M, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Anticancer Drugs. 2014 Jul;25(6):673-82. doi: 10.1097/CAD.0000000000000094.


Elastase, α1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis.

Polańska B, Augustyniak D, Makulska I, Niemczuk M, Jankowski A, Zwolińska D.

Arch Immunol Ther Exp (Warsz). 2014 Jun;62(3):239-45. doi: 10.1007/s00005-013-0265-7. Epub 2013 Nov 29.

Supplemental Content

Loading ...
Support Center